Structure of a protective epitope of group B Streptococcus type III capsular polysaccharide

Filippo Carboni,Roberto Adamo,Monica Fabbrini,Riccardo De Ricco,Vittorio Cattaneo,Barbara Brogioni,Daniele Veggi,Vittoria Pinto,Irene Passalacqua,Davide Oldrini,Rino Rappuoli,Enrico Malito,Immaculada y Ros Margarit,Francesco Berti
DOI: https://doi.org/10.1073/pnas.1701885114
IF: 11.1
2017-04-24
Proceedings of the National Academy of Sciences
Abstract:Significance This article describes the characterization of the antigenic determinant of the capsular polysaccharide from the clinically relevant serotype III of group B Streptococcus (GBS). NMR and X-ray crystallography have been applied to elucidate the interaction of type III GBS oligosaccharides obtained by synthetic and depolymerization procedures of the bacterial polysaccharide with a functional monoclonal antibody. A Fab–GBS oligosaccharide complex structure has been solved at high resolution (2.7 Å). The results demonstrate the existence of a sialic acid-dependent functional epitope of GBS that is fully contained within four consecutive sugars deriving from the type III GBS polysaccharide backbone and one branched disaccharide present in this sequence. This finding has implications for the development of vaccines against GBS infection.
What problem does this paper attempt to address?